Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8528066 | Clinical Therapeutics | 2018 | 15 Pages |
Abstract
In healthy Chinese individuals, administration of elbasvir and grazoprevir, alone or concomitantly, was generally well tolerated, with a thoroughly characterized PK profile. Elbasvir and grazoprevir exposures may trend higher in Chinese healthy participants relative to white healthy participants. Protocol number MK-5172 PN022.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Tommy Tsang MD, Joanne Wing MD, Man Fung MD, Karen Siu MD, Bernard Man MD, Hwa-Ping PhD, Wendy W. MD, Jiangdian PhD, Wenting MD, PhD, Xu Min MD, PhD, Zaiqi MD, PhD, Shengmei MD, PhD,